Public consultation for the 2016 evaluation of the EU Drugs Strategy and Action Plan on Drugs

Policy field(s)

Home Affairs; Anti-drugs; Public health

Target group(s)

All EU and non-EU citizens and stakeholders are welcome to contribute to this consultation. Contributions are sought from individuals, local, regional and national authorities, international and regional organisations, intergovernmental and non-governmental organisations, academic institutions, third countries, social partners and civil society.

Period of consultation

From 15/02/2016 to 31/05/2016

Objective of the consultation

The EU Drugs Strategy provides a political framework and priorities for actions in the field of drug policies for the period 2013-2020. It builds around two policy fields: drug demand reduction and drug supply reduction; and three cross-cutting themes: coordination, international cooperation and information, research, monitoring and evaluation.

The EU Drugs Strategy requests the Commission to initiate an external mid-term assessment by 2016, in view of preparing a second Action Plan for the period 2017-2020.

In the framework of this evaluation and following the Better Regulation Guidelines, the Commission is conducting a broad stakeholder consultation, including an open public consultation, as outlined also in the roadmap of the evaluation . The stakeholder consultation seeks to gather views from individual citizens, non-profit/private organisations, industry and from national/regional/local public administrations on all 5 objectives of the EU Drugs Strategy and corresponding actions of the Action Plan and on the key evaluation criteria: effectiveness, efficiency, relevance, coherence and EU value added. This public consultation will form part of the evidence base for the evaluation of the EU Drugs Strategy and Action Plan and the work ahead.

A Steering Group, made up all relevant Commission services and the European External Action Service (EEAS) chaired by DG HOME, is consulted regularly at all stages of this evaluation and it has approved the consultation strategy for this evaluation, as well as the questionnaire for the public consultation.

How to submit your contribution

You can contribute to this public consultation by filling in the online questionnaire which is available in English. You may pause at any time and continue later. Once you have submitted your answers, you can download a copy of your contribution.

Only responses received through the online questionnaire will be taken into account and included in the report summarising the responses.

In the interests of transparency, organisations (including, for example, NGOs, trade associations and commercial enterprises) are invited to provide the public with relevant information about themselves by registering in the Interest Representative Register and subscribing to its Code of Conduct.

If you are a Registered organisation, please indicate the name and address of your organisation and your Register ID number on the first page of your contribution. Your contribution will then be considered as representing the views of your organisation.

If your organisation is not registered, you have the opportunity to register now. Then return to this page to submit your contribution as a Registered organisation.

Responses from organisations not registered will be published separately.

The Commission asks organisations who wish to submit comments in the context of public consultations to provide the Commission and the public at large with information about whom and what they represent. If an organisation decides not to provide this information, it is the Commission's stated policy to list the contribution as part of the individual contributions. (Consultation Standards, see COM (2002) 704, and Communication on ETI Follow-up, see COM (2007) 127 of 21/03/2007).

Reference documents and other, related consultations

Background document for the public consultation for the 2016 evaluation of the EU Drugs Strategy and Action Plan on Drugs.

You can read the full text of the EU Drugs Strategy 2013-2020 and of the EU Action Plan on Drugs 2013-2016 .

In 2015 the Commission published a Progress report on the implementation of the EU Drugs Strategy and Action Plan covering the period 2013-2014, accompanied by a Staff Working Document.

You can also consult the EMCDDA's 2015 European Drug Report.

View the contributions

A total of 121 contributions were received. You will find below a list of all contributions where the participants agreed their contribution could be directly published together with the personal/organisation information.

For those participants who agreed that their contribution could be published anonymously an Excel file is available with the anonymized data.

The contributions of participants who did not agree to the publication of results were not published. They will, however, be taken into account when analysing the results of the public consultation.

National public authorities contributions

Private individuals contributions

International/Intergovernmental/Regional organisations contributions

Organisations (non-governmental, civil society organisation, academia, research, social partner, interest group, consultancy, think-tank…) or private companies contributions

It is important to read the specific privacy statement attached to this consultation for information on how your personal data and contribution will be dealt with. You may also read more on the general European Commission's Personal Data Protection policy.

Results of consultation and next steps

Responses to this questionnaire will be processed with the support of an external contractor and they will be included in a synopsis report.

The report of the results of the public consultation is now available.

Contact details

Responsible service:
European Commission
Directorate General Migration and Home Affairs
Unit D4 – Anti-Drugs Policy
E-mail:
HOME-JUSTPOLICYec [dot] europa [dot] eu (HOME-JUSTPOLICY[at]ec[dot]europa[dot]eu)

Deadline: from 02/07/2016 to: 02/07/2016